Back
Editas Medicine Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
37
EDIT
Editas Medicine
Last Price:
3.77
Seasonality Move:
10.81%
Buy
53
VRTX
Vertex Pharmaceuticals
Last Price:
464.85
Seasonality Move:
-0.92%
Sell
37
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $3.77. The Score for EDIT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $464.92. The Score for VRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $3.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $464.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 44.16 | Sell |
Chaikin Money Flow: | -268969 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.62 - 3.96) | Sell |
Bollinger Bands (100): | (4.08 - 5.62) | Sell |
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.62 | Sell |
Relative Strength Index (14 RSI): | 40.59 | Sell |
Chaikin Money Flow: | -1113659 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (472.1 - 487.96) | Sell |
Bollinger Bands (100): | (443.93 - 493.87) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.84 | Sell |
20-day SMA: | 3.74 | Buy |
50-day SMA: | 4.38 | Sell |
200-day SMA: | 6.55 | Sell |
8-day EMA: | 3.82 | Sell |
20-day EMA: | 3.85 | Sell |
50-day EMA: | 4.24 | Sell |
200-day EMA: | 6.02 | Sell |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 478.29 | Sell |
20-day SMA: | 479.1 | Sell |
50-day SMA: | 482.49 | Sell |
200-day SMA: | 440.47 | Buy |
8-day EMA: | 475.78 | Sell |
20-day EMA: | 477.9 | Sell |
50-day EMA: | 477.18 | Sell |
200-day EMA: | 441.03 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $1.22 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Editas Medicine Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vertex Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |